15icbd.jtbcom.co.jp
15th International Conference on Behçet’s Disease
POSTER PROGRAM
(
Friday, July 13)
Poster Session 1 Immunology and Genetics
P1-1-001 Behçet's Disease and HLA A26
Zemfira S Alekberova, M Krylov, Regina Goloeva, J Guseva, Evgenii L Nasonov
Research Institute of Rheumatology, Moscow, Russia
P1-1-002 Correlation between plasma homocysteine level and HLA-B51 in patients with Behçet's
disease and control group
Farhad Shahram, Sorayya Shademan-far, Abdolhadi Nadji, Maassoomeh Akhlaghi, Seyedeh Tahereh Faezi,
Bahar Sadeghi-Abdollahi, Alireza Faridar, Fereydoun Davatchi
Rheumatology Research Center, Tehran Univ. of Medical Sciences, Iran
P1-1-003 IL23R GENE POLYMORPHISM IS ASSOCIATED WITH BEHÇET'S DISEASE IN A
SECOND COHORT IN TURKEY
Ayca Duman1, Vusale Abbasova1, Fatma Alibaz-Oner2, Vuslat Yilmaz4, Tulin Ergun3, Haner Direskeneli2,
1Istanbul School of Medicine, Turkey, 2Istanbul School of Medicine, 3Marmara School of Medicine, 4Istanbul
School of Medicine, 5Marmara School of Medicine, 6Marmara School of Medicine, 7Istanbul School of Medicine
P1-1-004 Association study of IL10 and IL23R-IL12RB2 in Iranian Behçet's disease patients
Joana M. Xavier1,2, Farhad Shahram3, Fereydoun Davatchi3, Jorge Crespo4, Bahar S. Abdollahi3,
Gorete Jesus5, Jose V. Patto6, Niloofar M. Shafiee3, Fahmida Ghaderibarim3, Sofia A. Oliveira1,2
1Instituto de Medicina Molecular, Faculdade de Medicina da Univ.ersidade de Lisboa, Portugal, 2Instituto
Gulbenkian de Ciencia Oeiras, Portugal, 3Rheumatology Research Center Tehran Univ. of Medical Sciences,
Tehran, Iran, 4Centro Hospitalar e Univ.ersitario de Coimbra Portugal, 5Hospital Infante D. Pedro Aveiro,
Portugal, 6Instituto Portugues de Reumatologia Lisboa, Portugal
P1-1-005 Targeted deep re-sequencing implicates rare and low frequency coding variants in IL23R,
MEFV, TLR4, and NOD2 in Behçet's disease
Yohei Kirino1,2, Qing Zhou1, Yoshiaki Ishigatsubo2, Nobuhisa Mizuki3, Ilknur Tugal-Tutkun4,
Emire Seyahi5, Yilmaz Ozyazgan6, Akira Meguro4, Daniel L Kastner1, Ahmet Gül7, Elaine F Remmers1
1Inflammatory Disease Section, National Human Genome Research Institute, NIH, USA, 2Dept. Internal
Medicine and Clinical Immunology Yokohama City Univ., 3Dept. Ophthalmology and Visual Science Yokohama
City Univ., 4Istanbul Faculty of Medicine, Dept. Ophthalmology Istanbul Univ., 5Cerrahpasa Faculty of
Medicine, Dept. Internal Medicine Istanbul Univ., 6Cerrahpasa Faculty of Medicine, Dept. Ophthalmology
Istanbul Univ., 7Istanbul Faculty of Medicine, Dept. Internal Medicine, Div. Rheumatology Istanbul Univ.
P1-1-006 XBP1 SPLICING AND REDUCED XBP1 EXPRESSION IN BEHÇET'S DISEASE
Neslihan Abaci1, Fulya Cosan1, Hulya Azakli1, Sema Sirma-Ekmekci1, Zeliha Emrence1, Aris Cakiris1,
Micheal J Ombrello2, Duran Ustek1, Ahmet Gül1,3
1Dept. of Genetics, Institute for Experimental Medical Research, Istanbul Univ., Turkey, 2The Inflammatory
Disease Section National Human Genome Research Institute, Bethesda, United States, 3Div. of Rheumatology,
Dept. of Internal Medicine Istanbul Faculty of Medicine, Istanbul Univ., Turkey
P1-1-007 Analysis of interleukin 17A single nucleotide polymorphism in Behçet's Disease
Koichiro Nakamura1, Fumio Kaneko2, Akira Meguro3, Nobuhisa Mizuki3
1Dept. Dermatology, Saitama Medical Univ., Japan, 2Skin Unit Southern Tohoku General Hospital, 3Dept.
P1-1-008 TIR-domain-containing adaptor protein gene TIRAP S180L polymorphism in Behçet's
Gorkem Turunc1, Doga Coskun1, Fatma Alibaz-Oner2, Sibel P Yentur1, Tulin Ergun3, Haner Direskeneli2,
1Dept. of Physiology, I.U. Istanbul Medical Faculty, Turkey, 2Dept. of Rheumatology Internal Medicine
Marmara Medical School, 3Dept. of Dermatology Marmara Medical School
15th International Conference on Behçet’s Disease
P1-1-009 Targeted sequencing of candidate genes in Behçet's Disease
Hyeong Gon Yu1, Sang Jin Kim1, Hee Yoon Cho2, Jae Suk Kim3, Hum Chung1
1Dept. of Ophthalmology, Seoul National Univ. College of Medicine & Medical Research Center, Seoul National
Univ., Korea, 2Dept. of Ophthalmology Hanyang Univ. College of Medicine, 3Dept. of Ophthalmology Inje
P1-1-010 Expression and function of inducible costimulator on peripheral blood CD4 T cells in
patients with ocular Behçets disease: a new activity marker?
Yoshihiko Usui1,3, Masaru Takeuchi2, Takeshi Kezuka1, Yoko Okunuki1, Hisaya Akiba3, Hiroshi Goto1
1Ophthalmology, Tokyo Medical Univ. Hospital, Japan, 2Ophthalmology National Defense Medical College,
3Immunology Juntendo Univ. School of Medicine
P1-1-011 Role of TGFbeta/Smad pathway in T cell functions in patients with Behçet's disease
Jun Shimizu1, Naruyoshi Fujiwara1, Fumio Kaneko2, Sakae Kaneko3, Noboru Suzuki1
1Dept. of Immunology and Medicine, St. Marianna Univ. School of Medicine, Japan, 2Dept. of Dermatology
Fukushima Medical Univ., 3Dept. of Dermatology Shimane Univ. School of Medicine
P1-1-012 The B or not the B?A study into the role of the B-cell in Behçets disease
Tim B. van der Houwen1,2, Jasper H. Kappen1, Lieke S.J. Kamphuis1,2, Paul L.A. van Daele1,2,
Martin van Hagen1,2, Menno C. van Zelm2, Jan A.M. van Laar1,2
1Dept. Internal Medicine, section Clinical Immunology, ErasmusMC Rotterdam, The Netherlands, 2Dept.
P1-1-013 Selective accumulation of gamma-delta T lymphocytes and B B1 cells in anterior chamber
of eye in Behçets diasease
"Armenicum" Investigation Center, Malayan Eye Center, Yerevan, Armenia
Poster Session 2 Uveitis and threapy
P2-1-027 DEMOGRAPHIC, GENETIC AND CLINICAL FEATURES OF OCULAR
INVOLVEMENTS IN BEHÇET'S DISEASE IN TUNISIA
Thouraya Ben Salem, Fatma Said, Monia Khanfir, Amira Hamzaoui, Amel Braham, Mounir Lamloum,
Dept. Internal Medicine, La Rabta Univ. Hospital, Tunisia
P2-1-028 Characteristics of ocular involvement in Behçet's disease
Regina Georgievna Goloeva1, Vladimir Eduardovich Tankovskyi2, Zemfira Saddulaevna Alekberova1
1Research Institute of Rheumatology Russian Academy Medical Science, Moscow, Russia, 2Moscow Helmholtz
Research Institute of Eye Diseases
P2-1-029 Interpretation of ophthalmic photographs for the diagnosis of Behçet uveitis
Ilknur Tugal-Tutkun1, Sumru Onal2, Yilmaz Ozyazgan3, Merih Soylu4
1Dept. of Ophthalmology, Istanbul Univ., Istanbul Faculty of Medicine, Turkey, 2Dept. of Ophthalmology VK
Foundation American Hospital, Istanbul, 3Dept. of Ophthalmology Istanbul Univ., Cerrahpasa Medical School,
4Dept. of Ophthalmology Cukurova Univ., Faculty of Medicine
P2-1-030 Serum Vitronectin Levels in Patients with Behçet's Disease
Ali Yalcindag1, Aslihan Uzun2, Nilufer Yalcindag2, Yesim Gedik Oguz2, Namik Delibas1
1Dept. of Clinical Biochemistry, Diskapi Yildirim Beyazit Training and Research Hospital, Turkey, 2Dept. of
Ophthalmology Ankara Univ., Faculty of Medicine
P2-1-031 Alpha-enolase expression on the surfaces of monocytes in patients with Behçet and non-
Behçet uveitis
Tae Wan Kim1,2, Jae Seung Kang3, Jeeyun Ahn1,2, Hum Chung2, Hyeong Gon Yu2
1Dept. Ophthalmology, Seoul Metropolitan Government Seoul National Univ. Boramae Medical Center, Korea,
2Dept. Ophthalmology Seoul National Univ., College of Medicine, 3Dept. Anatomy and Tumor Immunity
Medical Research Center Seoul National Univ., College of Medicine
15th International Conference on Behçet’s Disease
P2-1-032 Detection of toll like receptors in Behçets disease with uveitis following infliximab
treatment
Takeshi Kezuka, Yoshihiko Usui, Yoko Okunuki, Naoyuki Yamakawa, Hiroshi Goto
Dept. of Ophthalmology, Tokyo Medical Univ., Japan
P2-1-033 Low vision care needs of patients with Behçet's disease
Tomomi Nishida1, Akiko Yamada1,2, Mayumi Komatsu1,2, Yuki Nishiwaki1,2, Marie Miwa1,2,
Tsutomu Nakanishi2, Akio Kubo2, Satoshi Nakadomari1,2
1Dept. Medical Treatment (2), Ophthalmology, Hospital, National Rehabilitation Center for Persons with
Disabilties, Japan, 2Dept. of Rehabilitation, Low Vision Training Hospital, National Rehabilitation Center for
P2-1-034 INFLIXIMAB THERAPY FOR UVEITIS IN BEHÇET' DISEASE
Kayo Terauchi1, Takeaki Uehara1, Ryusuke Yoshimi1, Atsushi Ihata1, Atsuhisa Ueda1, Etsuko Shibuya2,
1Dept. Internal Medicine and Clinical Immunology, Yokohama City Univ. Graduate School of Medicine, Japan,
2Yokohama City Univ. Graduate School of Medicine Dept. Ophthalmology
P2-1-035 Clinical efficacy of infliximab in patients with Behçet's disease
Takuma Wada, Yuji Akiyama, Kojiro Sato, Yu Funakubo, Toshihide Mimura
Dept. Rheumatology and Applied Immunology, Saitama Medical Univ., Japan
Poster Session 3 Mucocutaneous lesion
P3-1-046 Iron deficiency state in resistant oral aphthosis of Behçet's disease
Farhad Shahram, Taraneh Dormohammadi Toosi, S. Zahra Ghodsi, Abdolhadi Nadji,
Arash Tehrani Banihashemi, Roghieh Larimi, Fereydoun Davatchi, Cheyda Chams-Davatchi
Rheumatology Research Center, Tehran Univ. of Medical Sciences, Iran
P3-1-047 Fibromyalgia in Behçet disease is associated with disease activity.
Meryem Can1, Fatma Alibaz-Oner1, Sibel Yilmaz-Oner1, Nevsun Inanc1, Tulin Ergun2, Gonca Mumcu3,
1Dept. of Rheumatology, School of Medicine, Marmara Univ.,Istanbul,Turkey, 2Dept. of Dermatology,School
Of Medicine, Marmara Univ., Istanbul,Turkey, 3Faculty of Health Sciences, Dept. of Health Informatics and
Technologies Marmara Univ.,Istanbul,Turkey
P3-1-048 Quality of life and fatigue in patients with Behçet disease
Meryem Can1, Fatma Alibaz-Oner1, Birkan Ilhan1, Sibel Yilmaz-Oner1, Nevsun Inanc1, Tulin Ergun2,
1Dept. of Rheumatology, School of Medicine, Marmara Univ.,Istanbul,Turkey, 2Dept. of Dermatology,School
Of Medicine Marmara Univ., Istanbul,Turkey, 3Faculty of Health Sciences, Dept. of Health Informatics and
Technologies Marmara Univ.,Istanbul,Turkey
P3-1-049 Is Oral Aphthosis of Behçet Disease (BD) different from Idiopathic Recurrent Aphthous
Stomatitis (RAS)
Bahar Sadeghi Abdollahi, Fereydoun Davatchi, Cheyda Chams-Davatchi, Zahra Ghodsi, Farhad Shahram,
Abdolhadi Nadji, Tahereh Faezi, Massoomeh Akhlaghi, Farima Ashofteh, Mostafa Ghorbani
Rheumatology Research Center, Tehran Univ. of Medical Sciences, Iran
P3-1-050 THE STATUS OF SERUM VITAMIN D IN PATIENTS WITH RECRRENT
APHTHOUE COMPARED WITH CONTROLS
Sousan Kolahi1,2, Alireza Khabbazi1,2, Mehrzad Hajialiloo1,2, Sakinehkhatoun Sharif1,2, Zahra Jalali1
1Internal Medicine Dept./Tabriz Univ. of Medical Sciences, Iran, 2Rheumatology Research Team, Tabriz Univ.
P3-1-051 Fatigue Is An Important Problem in Patients with Behçet's Syndrome
Deram Buyuktas1, Gulen Hatemi2, Sukran Yuksel-Findikoglu2, Koray Tascilar2, Serdal Ugurlu2,
1Dept. Internal Medicine, Istanbul Univ. Cerrahpasa Medical School, Turkey, 2Dept. Internal Medicine,
Rheumatology, Istanbul Univ. Cerrahpasa Medical School
15th International Conference on Behçet’s Disease
P3-1-052 Therapeutic Role of Isotretinoin in Management of Recurrent Aphthous Stomatitis: Single
Blind Controlled therapeutic study
Khalifa E. Sharquie1, Raad Muhi Aldeen Helmi2, Adil A. Noiami3, Raafa K. Al-Hayani4,
1Scientific Council of Dermatology and Venereology, Iraqi Board for Medical Specializations, Iraq, 2Dept. of
Oral Medicine/College of Dentistry, Al-Mustansiriya Univ., 3Dept. of Dermatology/College of Medicine, Univ.
of Baghdad, 4Dept. of Dermatology, Baghdad Teaching Hospital, 5Dohuk Specialized Dental Center, General
Directorate of Health in Dohuk/Kurdistan
Poster Session 4 Neurological, vascular, and intestinal involvement
P4-1-064 Study of colonoscopic findings in intestinal Behçet's disease in Egyptian patients
Mohamed Nabil Rafat Farahat1, Mohamed Ibraheim Yousef1, Mahmoud Mosa Bazeed1,
Mohamed Noshy El-Alfy1, Ibraheim Hasan Mohamed2
1Dept. Internal Medicine, Faculty of Medicine, Al-Azhar Univ., Cairo, Egypt., 2Dept. Pathology Faculty of
Medicine, Al-Azhar Univ., Cairo, Egypt.
P4-1-065 The clinical course and treatment in patients with intestinal Behçet's disease; a single
center experience of current 30 cases
Yoshitaka Kimura1, Kurumi Asako1, Hirotoshi Kikuchi2, Akiteru Takeuchi1, Hajime Kouno1
1Dept. of Internal Medicine, Teikyo Univ. School of Medicine, Japan, 2Dept. of Microbiology and Immunology,
P4-1-066 Efficacy and Safety of Infliximab in Intestinal Behçet's Disease
Hiroto Kinoshita1, Reiko Kunisaki1, Hisae Yamamoto1, Reikei Matsuda1, Machiko Nakatogawa1,
Hideaki Kimura1, Katsuaki Tanaka2, Shin Maeda3
1Inflammatory Bowel Disease Center, Yokohama City Univ. Medical Center, Japan, 2Gastroenterology Center,
Yokohama City Univ. Medical Center, 3Dept. of Gastroenterology, Yokohama City Univ.
P4-1-067 NEUROLOGICAL INVOLVEMENT IN BEHÇETS DISEASE: DEMOGRAPHIC,
CLINICAL AND GENETIC FEATURES IN 121 TUNISIAN PATIENTS.
Thouraya Ben Salem, Nabil Bel Feki, Amira Hamzaoui, Monia Khanfir, Mounir Lamloum, Amel Braham,
Dept. Internal Medicine, La Rabta Univ. Hospital, Tunisia
P4-1-068 Neuropsychiatric involvement in Behçet s disease. Monocentric study of 43 patients.
Zoubida Tazi Mezalek, Hind Charadi, Wafa Ammouri, Hicham Harmouche, Mouna Maamar,
Internal medicine Dept., Ibn Sina hospital - Rabat - Morocco
P4-1-069 Pseudotumor cerebri as a presenting sign of Behçet Disease
Gulden Akdal1, Aylin Yaman2, Meltem Soylev Bajin2, Suleyman Men3, Gulsen Akman Demir4
1Dokuz Eylul Univ. Hospital Dept. of Neurology and Neurosciences, Turkey, 2Dokuz Eylul Univ. Hospital Dept.
of Ophthalmology, 3Dokuz Eylul Univ. Hospital Dept. of Radiology, 4Istanbul Bilim Univ. Dept. of Neurology
P4-1-070 Cerebral white matter lesions in Behçet disease: neuro-Behçet or multiple sclerosis?
Gulsen Akman-Demir1, Melike Mutlu2, Asli Kiyat-Atamer1, Erkingul Shugaiv2, Murat Kurtuncu4,
Ilknur Tugal-Tutkun3, Erdem Tuzun2, Sara Bahar2
1Istanbul Bilim Univ., Dept. of Neurology, Turkey, 2Istanbul Univ., Istanbul Faculty of Medicine Dept. of
Neurology, 3Istanbul Univ., Istanbul Faculty of Medicine Dept. of Ophthalmology, 4Acibadem Univ., Dept. of
P4-1-071 Restless legs syndrome in neuro Behçet's disease
Dept. Neurology, Ankara Univ. School of Medicine, Turkey
15th International Conference on Behçet’s Disease
Poster Session 5 Epidemiology
P5-1-081 The new International Criteria for Behçets Disease ICBD how affect the diagnosis of
Behçets Disease
Sakineh Khatoun Sharif, Zahra Jalali, Alireza Khabbazi, Mohammadreza Nakhjavani
Sina outpatient clinic, tabriz Univ. of medical science, Iran
P5-1-082 Epidemiological and clinical characteristics of Behçet's disease in Korea - using a clinical
database for patients' registry
So Young Na1, Ji-Hye Park1, Sung Bin Cho2, Suhyun Cho2, Dongsik Bang2, Joo Young Rho3,
Hyeong Gon Yu4, Chang Keun Lee5, Eun-So Lee1
1Dept. of Dermatology, Ajou Univ. School of Medicine, Korea, 2Dept. of Dermatology, Yonsei Univ. College
of Medicine, 3Dept. of Dermatology, Gachon Univ. of Medicine and Science, 4Dept. of Ophthalmology, Seoul
National Univ. College of Medicine, 5Dept. of Rheumatology, Asan Medican Center
P5-1-083 2012 Update of epidemiological data from the German Registry for Adamantiades-Behçet
Andreas Altenburg1,6, Alfred Mahr2, Carla Maldini2, Lothar Krause3,6, Thomas Stache4, Ina Koetter5,6,
Nikolaos G Bonitsis1,6, Nestor G Papoutsis6, Christos C Zouboulis1,6
1Dept. of Dermatology, Venereology and Allergology, Dessau Medical Center, Germany, 2Dept. of Internal
Medicine, Hospital Saint-Louis, Univ. of Paris,, 3Dept. of Ophthalmology, Dessau Medical Center, 4Dept. of
Neurology, Dessau Medical Center, 5Dept. of Internal Medicine, Univ. of Tuebingen, 6German Registry for
Adamantiades-Behçet Disease, Germany
P5-1-084 THE PREVALENCE OF BEHÇET'S DISEASE IN BASILICATA (LUCANIA) REGION
OF SOUTHERN ITALY: PRELIMINARY RESULTS
Salvatore D'Angelo, Pietro Leccese, Silvana Di Bello, Michele Gilio, Angelo Nigro, Carlo Palazzi,
Rheumatology Dept. of Lucania, San Carlo Hospital of Potenza and Madonna delle Grazie Hospital of Matera,
P5-1-085 Difference of clinical characteristics of Behçet's syndrome between the United States and
Yuri Ohara1, Mitsumasa Kishimoto1, Yasuharu Tokuda3, Hideto Oshikawa2, Kazuki Yoshida2,
Masako Utsunomiya4, Makiko Kimura2, Masato Okada1, Kazuo Matsui2, Yusuf Yazici5
1Div. Allergy & Rheumatology, St. Luke's International Hospital, Japan, 2Dept. Rheumatology Kameda Medical
Center, 3-, Univ. of Tsukuba, 4-, Japanese Red Cross Musashino Hospital, 5Div. Rheumatology, New York Univ.
School of Medicine and NYU Hospital for Joint Diseases
P5-1-086 Morbidity of solid cancer in Behçet's disease: analysis of 11 cases in a series of 506 patients
Dept. of Dermatology, Ajou Univ. School of Medicine, Korea
P5-1-087 Clinical similarity in patients with familial Behçet's disease in comparison to sporadic
Farhad Shahram, Roghieh Larimi, Arash Tehrani Banihashemi, Alireza Faridar, Nahid Shafaie,
S. Zahra Ghodsi, Massoomeh Akhlaghi, Abdolhadi Nadji, Fereydoun Davatchi
Rheumatology Research Center, Tehran Univ. of Medical Sciences, Iran
P5-1-088 Gender-specific presentation of Adamantiades-Behçet's disease (ABD) : systematic
literature review and meta-analyses
Liem Binh Luong Nguyen1, Nikolaos G Bonitsis2, Andreas Altenburg2, Christos C Zouboulis2,
1Dept. of Internal Medicine, Hospital Saint-Louis, Paris, France, 2Dept.s of Dermatology, Venereology,
Allergology and Immunology, Dessau Medical Center, Dessau, Germany
15th International Conference on Behçet’s Disease
Poster Session 6 Interesting cases
P6-1-098 A Case of HLA-B27 Positive but B51 Negative Intestinal Behçet's disease with Crohn's
disease-like Anal Fistulas
Tsuyoshi Kobashigawa1, Yuki Nanke1, Masakazu Takazoe2, Hisashi Yamanaka1, Shigeru Kotake1
1Institute of Rheumatology, Tokyo Women's medical Univ., Japan, 2Inflammatory Bowel Disease Center, Dept.
of Internal Medicine, Social Insurance Chuo General Hospital
P6-1-099 Remission of intestinal Behçet's disease after induction chemotherapy into acute myeloid
lukemia M4 inv16
Tadashi Sato1, Hiroyuki Ohtsuka1, Mitsuaki Sato1, Tomoyoshi Uetake1, Tatsuya Yamaguchi1,
Masahiko Ohtaka1, Nobuyuki Enomoto1, Tohru Mitsumori2, Keita Kirito2
1Dept. Gastroenterology, Univ. Yamanashi, Japan, 2Dept. Hematology Univ. Yamanashi
P6-1-100 Infliximab therapy for sigmoidvesical fistula in Behçet's disease; A case report
Makoto Inoue1, Hirohumi Mitomi2, Kouhei Azuma2, Takahiro Okazaki2, Hidehiro Yamada2,
1Div. of Rheumatology, St.Marianna Univ. School of Medicine, Yokohama City Seibu Hospital, Japan, 2Div. of
Rheumatology and allergy, St.Marianna Univ. School of Medicine
P6-1-101 Efficacy of infliximab in entero-Behçet's disease; two cases report
Masaomi Yamasaki, Makoto Inoue, Kumiko Tonooka, Naooki Katsuyama
Div. of Rheumatology, St.Marianna Univ. School of Medicine, Yokohama City Seibu Hospital, Japan
P6-1-102 Successful treatment with adalimumab in a patient with intestinal Behçet's disease after
secondary loss of response to infliximab
Toru Nakata1,2, Hideki Sakai1,2, Yasuhiro Iizuka1,2, Eiki Fujita1,2, Yuko Fujiwara1,2, Machi Yamamoto1,2,
Nahoko Mochizuki1,2, Masakazu Nagahori2, Mamoru Watanabe2
1Dept. Gastroenterology and Hepatology, Kashiwa City Hospital, Japan, 2Dept. Gastroenterology and Hepatology,
P6-1-103 Neuro-Behçet's disease presenting as aseptic meningitis and erythema nodosum-like
lesions.
Aki Honda, Saori Watanuki, EmI Yasuoka, Ko-Ron Chen
Dept. of Dermatology, Saiseikai Central Hospital, Tokyo, Japan
P6-1-104 Bilateral Optic Neuritis in a patient with Behçet Disease
Seyda Erdogan1, Nilufer Yalcindag2, Mine Hayriye Sorgun1, Huban Atilla2, Canan Yucesan1
1Dept. Neurology, Ankara Univ., School of Medicine, Turkey, 2Dept. Ophthalmology, Ankara Univ., School of
P6-1-105 A Rare Form of Neuro-Behçet Disease: Anterior spinal cord syndrome
Sedat YILMAZ1, Kutay TEZEL2, Ramazan OCAL3, Turan ILICA4, Muhammet CINAR1,
Hakan ERDEM1, Salih PAY1, Ayhan DINC1, Ismail SIMSEK1
1Div. of Rheumatology, Gulhane School of Medicine, Turkey, 2Dept. of Physical Therapy and Rehabilitation,
Gulhane School of Medicine, 3Dept. of Intensive Care Unit, Gulhane School of Medicine, 4Dept. of Radiology,
P6-1-106 Behavioral and Cognitive Impairment in Neuro Behçet disease: Case report
Ayse Caglar Sarilar, Cigdem Kudiaki, Canan Yucesan
P6-1-107 Successful treatment with infliximab for two cases of neuro-Behçet's disease
Toshiyuki Watanabe, Shinsuke Yasuda, Yusaku Kanetsuka, Michihito Kono, Takashi Kurita,
Toshio Odani, Yuichiro Fujieda, Kotaro Otomo, Yujiro Kon, Tetsuya Horita, Tatsuya Atsumi
Dept. of Medicine II, Hokkaido Univ. Graduate School of Medicine, Japan
P6-1-108 A case of Behçet's disease developing after poststreptococcal acute glomerulonephritis
Yuichiro Kitai, Kosaku Murakami, Hajime Yoshifuji, Naoichiro Yukawa, Daisuke Kawabata,
Koichiro Omura, Takao Fujii, Tsuneyo Mimori
Dept. of Rheumatology and Clinical Immunology, Kyoto Univ. Graduate School of Medicine, Japan
Source: http://15icbd.jtbcom.co.jp/pdf/poster13.pdf
Adobe Digital Publishing Suite Solution BriefTablet devices represent a new and exciting platform for large enterprises to publish content to restricted or Benefits of publishing content The adoption of Apple iPad and other tablet devices within large organizations is exploding. Tablets are privately on tablets: powerful media consumption devices. At the same time, tablets provide a con
Recent combined hormonal contraceptives (CHCs) and the risk ofthromboembolism and other cardiovascular events in new usersStephen Sidneya,⁎, T. Craig Cheetham b, Frederick A. Connell c,Rita Ouellet-Hellstrom d, David J. Graham d, Daniel Davis d, Michael Sorela,Charles P. Quesenberry, Jr.a, William O. CoopereaDivision of Research, Kaiser Permanente Northern California, Oakland, CA 94612,